Biotechnology News & Press Release Distribution

Biotechnology

APAC
Global

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

New facility expands integrated drug product R&D and manufacturing services to global customers SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of its first high potency (HP) o...

2022-09-26 20:00 1391

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world's premier diabetic foot conference (DFCon) in Los Angeles

- CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with DrWong Keng Lin Francis, CRC's latest KOL, presenting his findings to world leaders in the field of DFU. - Similarly, the results of Corlicyte™'s Phase 1 study on the treatment of chro...

2022-09-26 13:44 1403

CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy

HANGZHOU, China, Sept. 26, 2022 /PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop, manufacture and commercialize proprietary "off-the-shelf" induced pluripotent stem cell- (iPSC) derived Chimeric An...

2022-09-26 12:31 1305

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases

Advancement highlights Everest's potential in providing first-in-class therapies to global patients with glomerular disease SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focu...

2022-09-26 08:00 2259

Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities

SINGAPORE, Sept. 23, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the official opening of its office and research facilities at the Singapore Sc...

2022-09-23 17:00 1684

WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED

$15.75 Million in Prizes Awarded for Predicting Protein Structure with Deep Learning, Pioneering Field of Quantum Information, and Discoveries with Applications from Treating Neurodegenerative Disease to Optimizing Video Transmission Breakthrough Prize in Life Sciences Awarded to Clifford P. Bra...

2022-09-22 21:25 1897

WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

-- CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells -- CK0803 represents the company's fifth program to receive IND Clearance utilizing Cellenkos' proprietaryCRANE™ technology HOUSTON, Sept. 22, 2022 /PRNewswire/ -- Cellenkos, Inc., a clinical stage bio...

2022-09-22 13:59 1215

Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential

SUZHOU, China and ROCKVILLE, Md., Sept. 21, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that the results from a Phase I and Phase II study of ...

2022-09-21 22:49 1393

Far Eastern New Century won the "Sustainability & Innovation Award" from ITMF Awards 2022 with FENC® TOPGREEN® Bio3

FENC® TOPGREEN® Bio3, World No.1 Fabric made from waste gas reuse technology & N66 solution dye. TAIPEI, Sept. 21, 2022 /PRNewswire/ -- As the pioneer in innovation and sustainability, Far Eastern New Century Corporation (FENC) is able to provide solutions to lower the environmental impact for b...

2022-09-21 20:00 1656

HIKE Capital rides green wave to seize future

BEIJING and SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- As the world is undergoing an energy restructuring, HIKE Capital, a leading founders' fund in China, has been committed to seizing the opportunities that emerged in the new era, which has been shaped by carbon reduction and digital technology. ...

2022-09-21 13:53 1678

HIKE Capital rides green wave to seize future

Excelra partners with Patcore, Inc.

The partnership expands Excelra's scientific products footprint in the Japanese market HYDERABAD, India and TOKYO, Sept. 21, 2022 /PRNewswire/ -- Excelra today announced a partnership with Patcore, Inc., providing greater access to Excelra's scientific data and analytics products for customers i...

2022-09-21 12:30 2788

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd (SCG), has announced today the establishment of a state-of-the-art cell therapy research and manufacturing hub inSingapore. With the support of the Singapore Economic Development Board (EDB), the hub comprises a pi...

2022-09-21 11:00 2674

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[131I] iodo-phenylalanine, or 131 I-IPA) in combination with external beam radiation therapy (EBRT)...

2022-09-21 07:51 1184

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

PALO ALTO, Calif., Sept. 20, 2022 /PRNewswire/ -- Koji Tanabe of I Peace, Inc. ( https://www.ipeace.com ) and a researcher Hiroko Nobuta of theUniversity of California, San Francisco (currently assistant professor at Rutgers University) successfully achieved the direct repr...

2022-09-21 05:39 1034

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment

GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluatin...

2022-09-21 05:33 1215

Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy

Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tr...

2022-09-20 19:25 1251

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...

2022-09-20 17:00 2009

Jialian Biotech Group To Participate At Vitafoods Asia 2022 In Bangkok

TAIPEI, Sept. 20, 2022 /PRNewswire/ -- Leading Taiwanese health-care supplements manufacturer Jialian Biotech Group (Jialian) is excited to announce its participation in Vitafoods Asia 2022 –Asia's leading nutraceutical event – inBangkok from October 5th to October 7th, 2022. Headquartered in T...

2022-09-20 14:01 1771

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received reg...

2022-09-20 10:48 1657

Angel Yeast Launches Premium Dry Yeast to Cater to Changing Global Baking Needs at Bakery China 2022

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer announces that it has developed the latest dry yeast product Premium Dry Yeast to address many of today's baking challenges at Bakery China 2022 -- a global large...

2022-09-20 10:47 2763

Angel Yeast Launches Premium Dry Yeast to Cater to Changing Global Baking Needs at Bakery China 2022

1 ... 110 111 112113114 115 116 ... 279